FdaApplication
NDA 209195
Identifiers
- fda_app_no: NDA209195
Properties
| Property | Value |
|---|---|
| applicant_name | GILEAD SCIENCES INC |
| application_type | NDA |
| approval_date | 2017-07-18 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VOSEVI | SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR | 400MG;100MG;100MG | TABLET;ORAL |
1 product